AstraZeneca PLC (AZN)
162.14
-0.56
(-0.34%)
USD |
NYSE |
Aug 31, 16:00
162.14
0.00 (0.00%)
After-Hours: 17:59
AstraZeneca Total Long Term Debt (Quarterly) : 30.91B for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 30.91B |
| December 31, 2025 | 28.97B |
| September 30, 2025 | 30.92B |
| June 30, 2025 | 30.81B |
| March 31, 2025 | 30.25B |
| December 31, 2024 | 29.96B |
| September 30, 2024 | 31.26B |
| June 30, 2024 | 30.48B |
| March 31, 2024 | 33.09B |
| December 31, 2023 | 28.09B |
| September 30, 2023 | 28.06B |
| June 30, 2023 | 29.42B |
| March 31, 2023 | 30.84B |
| December 31, 2022 | 28.86B |
| September 30, 2022 | 28.56B |
| June 30, 2022 | 28.78B |
| March 31, 2022 | 30.29B |
| December 31, 2021 | 30.37B |
| September 30, 2021 | 31.31B |
| June 30, 2021 | 26.94B |
| March 31, 2021 | 19.55B |
| December 31, 2020 | 19.72B |
| September 30, 2020 | 21.12B |
| June 30, 2020 | 17.95B |
| March 31, 2020 | 17.88B |
| Date | Value |
|---|---|
| December 31, 2019 | 18.00B |
| September 30, 2019 | 17.93B |
| June 30, 2019 | 19.08B |
| March 31, 2019 | 19.53B |
| December 31, 2018 | 18.36B |
| September 30, 2018 | 19.82B |
| June 30, 2018 | 16.85B |
| March 31, 2018 | 17.08B |
| December 31, 2017 | 16.96B |
| September 30, 2017 | 16.92B |
| June 30, 2017 | 18.57B |
| March 31, 2017 | 16.40B |
| December 31, 2016 | 16.36B |
| September 30, 2016 | 16.61B |
| June 30, 2016 | 17.58B |
| March 31, 2016 | 16.31B |
| December 31, 2015 | 14.20B |
| September 30, 2015 | 8.339B |
| June 30, 2015 | 8.363B |
| March 31, 2015 | 8.326B |
| December 31, 2014 | 9.357B |
| September 30, 2014 | 7.527B |
| June 30, 2014 | 7.574B |
| March 31, 2014 | 7.553B |
| December 31, 2013 | 9.384B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| GSK Plc | 18.51B |
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |
| Novo Nordisk A/S | 18.63B |